• SNS-032: Reading CDK9 Through RNA Pol II

  2026-09-25

  SNS-032 (BMS-387032) links CDK inhibition to measurable changes in RNA polymerase II phosphorylation. This article explains how to interpret those changes in cancer research—and why a SARS-CoV-2 release study offers a useful, but carefully bounded, perspective on CDK9 biology.

• 5-(N,N-dimethyl)-Amiloride in Endothelial Studies

  2026-09-25

  Use 5-(N,N-dimethyl)-Amiloride hydrochloride to test whether Na+/H+ exchange contributes to pH shifts and barrier changes in endothelial injury models. Paired with moesin, signaling, and permeability readouts, it adds a functional ion-transport perturbation—but does not substitute for the direct moesin-silencing evidence in the sepsis study.

• SW033291: 15-PGDH Inhibitor Workflows

  2026-09-24

  Use SW033291 to connect 15-PGDH target engagement with PGE2 measurements and functional regeneration readouts. This workflow guide also shows how to investigate muscle repair during GLP-1 receptor agonist–associated weight loss—while keeping the reference study’s findings distinct from compound-specific evidence.

• CHIR-99021 and the Timing of Neuronal Maturation

  2026-09-24

  CHIR-99021 (CT99021) is widely used to manipulate GSK-3 signaling during stem-cell differentiation. This article examines a less explored question: how to distinguish an early pathway response from the later, post-transcriptionally controlled events that establish neuronal axon identity.

• DIDS: Applied Workflows for Channel and Cancer Studies

  2026-09-23

  DIDS offers a practical way to perturb anion transport in channel, smooth-muscle, and cell-stress experiments—but its broad pharmacology makes orthogonal controls essential. This guide turns reported potency data and a metastasis-related cell-survival study into cautious, testable workflows, with solubility and interpretation checks built in.

• EZH2 Maintains the Epithelial State in Breast Cancer

  2026-09-23

  This preprint identifies an unexpected function for EZH2 in breast carcinoma: rather than simply promoting dissemination, EZH2 represses mesenchymal genes and helps cells remain toward the epithelial end of the EMT spectrum. Using reversible TGF-β-induced EMT, pharmacological EZH2 inhibition, and human tumor analyses, the study proposes a conserved PRC2 mechanism with implications for cancer epigenetics research and therapeutic interpretation.

• Cimetidine: H2R Biology and BBB Assay Strategy

  2026-09-22

  Cimetidine is a histamine-2 receptor antagonist with partial H2 receptor activity and a pharmacological profile distinct from ranitidine and famotidine. Its product properties support controlled receptor, cancer research, and BBB assay workflows, but the cited BBB study does not establish clinical brain exposure.

• Viral RIPK3 Degradation Controls Inflammation

  2026-09-22

  Liu and colleagues identified a viral inducer of RIPK3 degradation, or vIRD, that connects orthopoxvirus immune evasion with SCF-dependent proteolysis and necroptotic inflammation. The study combines screening, biochemical validation, engineered viruses, and mouse genetics to show that vIRD can reshape viral replication, inflammation, and disease severity.

• LGK-974: A Translational Map for PORCN Inhibition

  2026-09-21

  LGK-974 is a potent PORCN inhibitor that suppresses Wnt ligand maturation and secretion upstream of receptor engagement. This thought-leadership analysis connects its use in Wnt-dependent cancer models with emerging evidence in sclerosteosis, offering translational researchers a framework for biomarker selection, experimental design, and cross-domain interpretation.

• SNS-032: CDK9 Signaling and Viral Egress

  2026-09-21

  SNS-032 (BMS-387032) is a selective CDK2, CDK7, and CDK9 inhibitor for dissecting transcription, cell-cycle signaling, and cancer biology. This article translates its RNA polymerase II phosphorylation profile into a practical framework for interpreting host-factor studies of SARS-CoV-2 release without conflating evidence for SNS-032 with evidence for CDKI-73.

• Amiloride (MK-870) Workflow for Ion Transport

  2026-09-20

  Amiloride (MK-870) provides a practical perturbation tool for separating epithelial sodium flux, receptor-associated signaling, and cellular uptake in mechanistic assays. This workflow also shows how to use the compound as a hypothesis-testing control when studying phosphatidylinositol nanoliposomes and cellular immunity, without assuming that the nanovaccine study directly tested amiloride.

• ARCA EGFP mRNA as a Delivery Calibration Tool

  2026-09-19

  ARCA EGFP mRNA can function as more than a transfection control: it provides a functional readout for separating nucleic-acid delivery, translation, and cell recovery. This article connects fluorescence-based transfection assays with impedance-monitored in situ electroporation to improve experimental interpretation.

• RNAi Screen Maps SARS-CoV-2 Release Factors

  2026-09-18

  Kerr et al. used an arrayed druggable-genome RNAi screen with two-timepoint viral production measurements to identify host factors acting across the SARS-CoV-2 replication cycle. The study highlights Rab11a-dependent vesicular transport as a conserved release pathway and shows that CDK9 inhibition with CDKI-73 can block viral egress, providing a mechanistic basis for host-directed antiviral investigation.

• Mouse Tissue Lysis Kit (K1038) Protocol Guide

  2026-09-18

  The Mouse Tissue Lysis Kit (K1038) provides a direct route from mouse tail, toe, or ear tissue to PCR-ready genomic material for genotyping assays, without a separate DNA extraction or purification step. It is intended for molecular biology research and DNA analysis, not for diagnostic, clinical, or medical use.

• DMA: Translational Control of NHE1 Signaling

  2026-09-17

  A translational framework for using 5-(N,N-dimethyl)-Amiloride hydrochloride to connect intracellular pH regulation, sodium transport, endothelial injury, and cardiac dysfunction research.

8518 records 1/568 page Next 12345 下5页 Last page